In cancer patients who have compromised immune systems, T-cell activator provides protection against coronaviruses.

Published Date: 30 Aug 2023

For individuals with inherited or congenital immunodeficiency, there is good news: The outcomes of a clinical phase II study at the University Hospital Tübingen directed by Prof. Dr. Juliane Walz and Prof. Dr. Helmut Salih exhibits effectiveness.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How access to specialized cancer centers affects glioblastoma outcomes

2.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

3.

Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.

4.

U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain

5.

Beyond What Is Visible in Myelofibrosis?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot